Member Info for Newuncle

Mikey, yes based on the multiple patents that OBD has in place.

Andy,

Great advice, I know because it saved my life. Prostate cancer is biggest cancer killer of men in the UK. Testing is essential but most men avoid having one because they don't want to hear if they have it, that needs to change.

Andy,

No link with pyc, I think Laura is just highlighting increased awareness of prostate cancer in general will be beneficial to pyc, nothing more than that.

Hi Ritchie

Same here and ended up having surgery 5 years ago.

This is a real game changing development and could benefit millions of men every year .

It's fantastic breakthrough

Dr Naomi Elster, from the charity Prostate Cancer Research which has been funding research into the new test, said: “What’s really exciting and game-changing about this test is not only that it could be more accurate than tests we use now, but that it’s a cheap PCR test, like a covid test, that should be easy to use.”

And now they are all moaning that UK market is still in Sumer mode with little action.......hmmm

Rias, well done then, I have also been here for a while too.......I suggested this share to jiffybag poster on GST a while back and he replied that as I was the only poster on this BB it was a red flag share to avoid....that was back around 10p I think.....doh

This is going to be huge, the next Equals plc. Welcome Rias

Sad, very sad person who wants to knock a company at every opportunity that's working to help improve cancer treatments, he should think on that 1 in 3 adults are likely to be affected by cancer at some point in their lives.

share14 - 26 Sep 2023 - 10:42:34 - 11240 of 11241 Physiomics - Cancer Treatment tech firm working with Merck + Oxford Uni - PYC

discussion on who's attending a conference now on lse. barrel scraping or what.

Hi Kid,

Fine with me if CSO is officially attending but I still reckon Dr Peter Sargent will be there too one way or another,

BioForward 2023

Tuesday 26 September, The Kings Centre, Oxford

Sounds like the prefect event for PYC to be involved with, sure our new COO will be linking up with some friends?

BioForward 2023

Tuesday 26 September, The Kings Centre, Oxford

After record numbers in 2022, BioForward is back and bigger than ever!

BioForward is OBN's 'Roadmap for Growth' Life Sciences event, designed to provide the support, skills, know-how and industry connections required to build a commercially successful business.

Now in its fifth year, BioForward is attended by leaders and decision makers of growing R&D companies across all therapy and technological areas, alongside companies who provide services that help support the sustainable growth of emerging companies throughout the life sciences ecosystem.

BioForward Features:

An Industry exhibition showcasing 50 trusted industry suppliers, specialising in a range of services, including: Pre-clinical and clinical development, IP, tax & financial management, regulatory compliance, insurance, facilities, location management, manufacturing, lab supplies, communications, sales & marketing, business development, new technology, consultancy, HR & talent

A series of focused and practical workshop sessions

A full day of pre-scheduled, in-person 1-2-1 partnering meetings powered by PartneringONE

Physiomics at BioForward today

Discover our cutting-edge mathematical modelling solutions to help you make informed decisions at all stages of oncology R&D.

Buyers all over this now

And people are buying again today

BUY more

Oh I get it, what a great share CSFS.....of course, thanks

And your point is?

I can neither confirm or deny that, just buy the shares before they take off.

Recently, after immense efforts and logistics, the Company's U.S. based Tier 1 Aerospace client received U.S. Government approval to work with the Company on a military project that is based on the ENET Data processor adapted for the aviation market.